Today’s article highlights for biotech stocks for the new year. Here’s what they had to say, “Can we expect a better 2016 for this exciting sector? It has gotten some negative focus lately due to the buy-and-raise antics surrounding a certain controversial biotech CEO named Martin Shkreli who, to add insult to injury, just happened to get himself arrested on charges of securities fraud. Overall though, there are too many exciting late-stage trials going on for biotechs large and small that could materially change the sector for the better.” To check out the stocks and to read more, CLICK HERE.